SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -2.50 (-1.16%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £171.67m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

Trading Update

7 Feb 2018 07:00

RNS Number : 1037E
Warpaint London PLC
07 February 2018
 

 

7 February 2018

 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

 

 

Trading Update

 

Warpaint London PLC (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 brand, is pleased to announce the following trading update for the year ended 31 December 2017.

 

The Group continued to perform well during 2017 and the Board confirms that it expects to report results in line with management expectations for the financial year. 

 

The integration of Retra, acquired in November 2017, has been completed and the Retra business is performing well. A new managing director and finance director for Retra were appointed in December 2017 to drive this business forward and work with other Group management to maximise the opportunities available to the combined Group.

 

The Company will announce its results for the year ended 31 December 2017 in late April 2018.

 

Commenting, Sam Bazini and Eoin Macleod, Joint Chief Executives of Warpaint, said:

 

"We are very pleased with the performance of the Group in 2017. Retra has integrated well with the rest of the Group and we are already seeing new opportunities and synergies from the combination.

 

"2018 has started well and we look forward to the future with confidence."

 

 

Enquiries:

 

Warpaint London PLC

Sam Bazini - Joint Chief Executive Officer

Eoin Macleod - Joint Chief Executive Officer

Neil Rodol - Chief Financial Officer

 

c/o IFC

 

Stockdale Securities Limited (Nominated Adviser and Broker)

Antonio Bossi, Ed Thomas - Corporate Finance

Fiona Conroy - Corporate Broking

 

020 7601 6100

 

IFC Advisory Limited (Financial PR & IR)

Tim Metcalfe

Graham Herring

Heather Armstrong

Miles Nolan

020 3934 6630

 

 

 

About Warpaint London PLC

 

Warpaint is a colour cosmetics business, based in Iver, Buckinghamshire. It is made up of two divisions: close-out and own-brand. The second and larger own-brand division consists primarily of the Group's flagship brand, W7 - an extremely creative, design-focused cosmetic brand proposition with a focus on the 16-30 age range, delivering high-quality cosmetics at affordable prices. The W7 brand has grown organically since its inception in 2002 and now contains over 680 items which are sold into high street retailers and independent beauty shops across the UK, Europe, Australia and the US. In 2016, W7 was supplied to over 250 customers in more than 50 countries.

 

In November 2017 Warpaint acquired Retra Holdings, a UK colour cosmetics business with a significant focus on the gifting market. Retra owns three major brands: Technic, Body Collection and Man's Stuff, in addition to white label cosmetics produced for several major high street retailers.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSEFMMFASELE
Date   Source Headline
22nd May 20267:00 amRNSNotice of AGM and Posting of Annual Report
29th Apr 20267:00 amRNSResults for the year ended 31 December 2025
20th Apr 20267:00 amRNSNotice of Results
9th Apr 20269:41 amRNSBlock Listing Return
17th Feb 20261:34 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSRule 19.6(c) confirmation re Brand Architekts
9th Feb 20262:21 pmRNSCompletion of the acquisition of the Barry M brand
9th Feb 20267:00 amRNSAcquisition of Barry M brand & FY25 Trading Update
24th Nov 202512:16 pmRNSHolding(s) in Company
10th Nov 20252:06 pmRNSBLOCK LISTING RETURN
29th Oct 20252:52 pmRNSHolding(s) in Company
9th Oct 20251:36 pmRNSBlock listing Return
8th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
17th Sep 20259:12 amRNSHolding(s) in Company
10th Sep 20257:00 amRNSInterim Results
2nd Sep 20257:00 amRNSNotice of Results
21st Aug 20252:23 pmRNSHolding(s) in Company
19th Aug 20258:21 amRNSHolding(s) in Company
17th Jun 202510:46 amRNSResult of AGM
17th Jun 20257:00 amRNSAGM Statement
28th May 20252:43 pmRNSHolding(s) in Company
20th May 202512:01 pmRNSHolding(s) in Company
20th May 20257:30 amRNSNotice of AGM and Posting of Annual Report
13th May 20254:54 pmRNSBlock listing Interim Return
29th Apr 20257:00 amRNSResults for the year ended 31 December 2024
14th Apr 20257:00 amRNSNotice of Results
9th Apr 20253:07 pmRNSBLOCK LISTING RETURN
24th Mar 20251:38 pmRNSAnnouncement pursuant to AIM rule 13
13th Feb 20253:18 pmGNWForm 8.3 - Warpaint London Plc
13th Feb 20251:52 pmRNSForm 8.3 - Warpaint London plc
13th Feb 202512:17 pmRNSForm 8.3 - Warpaint London Plc
13th Feb 202511:50 amRNSForm 8.5 (EPT/RI)
13th Feb 202511:24 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
12th Feb 20255:56 pmRNSForm 8.3 - Warpaint London plc Amend
12th Feb 20253:46 pmRNSDirector/PDMR Dealing
12th Feb 20253:37 pmRNSApplication for Admission of Shares and TVR
12th Feb 20253:25 pmRNSReplacement: Scheme Effective
12th Feb 20253:10 pmRNSForm 8.3 - Warpaint London plc
12th Feb 20252:41 pmGNWForm 8.3 - Warpaint London Plc
12th Feb 20252:19 pmRNSForm 8.3 - Warpaint London Plc
12th Feb 202512:05 pmPRNForm 8.3 - Warpaint London Plc
12th Feb 202511:48 amRNSForm 8.3 - Warpaint London plc
12th Feb 202511:35 amRNSForm 8.3 - Warpaint London PLC
12th Feb 202510:59 amRNSForm 8.5 (EPT/RI)
12th Feb 202510:54 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
11th Feb 20253:04 pmGNWForm 8.3 - Warpaint London Plc
11th Feb 202512:19 pmRNSForm 8.3 - Warpaint London plc
11th Feb 202511:03 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
11th Feb 202510:49 amRNSForm 8.5 (EPT/RI)
11th Feb 202510:36 amRNSForm 8.3 - Warpaint London plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.